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㩷 1) 㩷 Hamazaki T., Kirihara Y.: Correlation between low cholesterol levels and high all-cause mortality- 
results from meta-analysis in Japan-, In what areas are traditional / alternative medicimes useful? 
Hamazaki T., Nagasawa T., Okuyama H.(ed.) 19-27, Proceedings of 11th International Symposium 
on Traditional Medicine in Toyama 2007, 2008.㩷
㩷 2)㩷 Hamazaki T., Okuyama H.: The Japanese Experience. High Cholesterol is Not an Important Risk 
Factor of All-Cause Mortality, Wild-Type Food in Health Promotion and Disease Prevention. The 
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Columbus Concept, Fabien De Meester, Ronald Ross Watson (ed.) 21-28, Humana Press INC. 
Totawa, New Jersey, 2008.㩷
㩷 3)㩷 Awale S., Hamazaki T., Kadowaki M., Saiki I., Tezuka Y., Kadota S.: Chapter 4 Commonly 
Encountered diseases in Traditional Medicine, Myanmar Traditional Medicine Handbook. 
MINISTRY OF HEALTH Department of Traditional Medicine, 99-120, 2008.㩷
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㩷 1) Itomura M., Fujioka S., Hamazaki K., Kobayashi K., Nagasawa T., Sawazaki S., Kirihara Y., 
and Hamazaki T.: Factors Influencing EPA+DHA Levels in Red Blood Cells in Japan. in
vivo. 22: 131-136, 2008. 
㩷 Abstract: The blood eicosapentaenoic and docosahexaenoic acid (EPA+DHA) concentration is an 
important inverse risk factor for sudden cardiac death. However, it is not known what kinds of factors 
influence the EPA+DHA levels in the total phospholipid fraction in red blood cells (RBC EPA+DHA) in 
Japan, who regularly eat more fish with increasing age. Four hundred and fifty-six healthy individuals 
(320 men and 136 women, 18 to 70 years old) were recruited between 2002 and 2005. RBC EPA+DHA 
were measured by gas chromatography and questionnaires were administered. Multivariate analysis 
indicated that there were significant correlations between RBC EPA+DHA and (i) dietary EPA+DHA 
(beta=0.31), (ii) age (beta=0.33), (iii) gender (beta=-0.15) and (iv) physical activity (beta=-0.11) but not 
with body mass index or smoking.
㩷
㩷 2) Kirihara Y., Hamazaki K., Hamazaki T., Ogushi Y., Tsuji H., and Shirasaki S.: The 
Relationship between Total Blood Cholesterol Levels and All-cause Mortality in Fukui City, 
and Meta-analysis of This Relationship in Japan. J. Lipid Nutr. 17: 67-78, 2008. 
㩷 Abstract: Summary: Shirasaki published a Japanese paper about the relationship between total 
cholesterol levels and all-cause mortality in Fukui City, Japan. His cholesterol data were not grouped 
according to ordinal 20mg/dL (0.52 mmol/L) intervals. In the present study, we re-calculated his data for 
meta-analysis. The relative risk (RR) of all-cause mortality adjusted for age and sex showed a decreasing 
trend with total cholesterol levels (p for trend <0.0001). In order to summarize the relationship between 
total cholesterol and all-cause mortality, literature describing this relationship in Japan was collected 
mainly using computer search engines. Literature published before 1995 was excluded. Reports with the 
total number of study subjects smaller than 5,000 were also excluded. Five reports were found suitable for 
meta-analysis of cholesterol levels and all-cause mortality. Meta-analysis revealed that the RR in the <160 
mg/dL (<4.14 mmol/L) group [RR=1.71 (1.41, 2.08)] was significantly higher than in the reference group 
[ 160-199 mg/dL (4.14-5.17 mmol/L)], and that the RRsin the 200-239 mg/dL (5.18-6.21 mmol/L) group 
[RRs=0.83 (0.74. 0.94)] and ҈240 mg/dL (҈6.22 mmol/L) group [0.78 (0.65, 0.95)] were significantly 
lower than in the reference group when both men and women were combined. We suggest that Japanese 
subjects with cholesterol levels ҈ 240 mg/dL (҈ 6.22 mmol/L) should not be regarded as 
hypercholesterolemic or dyslipidemic except when having some genetic disorders like familial 
hypercholesterolemia because they are in the safest ranges in terms of all-cause mortality.
㩷
㩷 3) Hamazaki K., Din Syafruddin., Insan S Tunru., Marina F Azwir., Puji BS Asih, Sawazaki S., 
and Hamazaki T.: The effect of docosahexaenoic acid-rich fish oil on behavior, school 
attendance rate and malaria infection in school children –a double-blind, randomized, 
placebo-controlled traial in Lampung, Indonesia. Asia Pac J Clin Nutr. 17: 258-263, 2008. 
㩷 Abstract: BACKGROUND: There are only a very limited number of reports of intervention studies on 
the effects of fish oil on behavior in normal school children. OBJECTIVE: To observe the effects of fish 
oil on behavior and school attendance rates in school children. DESIGN: Fourth to sixth graders (mostly 
9-12 years of age) of an elementary school in Lampung Province, Indonesia, were randomly divided into 
either a docosahexaenoic acid (DHA) group (n=116) or a control group (n=117) in a double-blind manner. 
The subjects in the DHA group took 6 fish oil capsules per day (0.65 g DHA and 0.10 g eicosapentaenoic 
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acid (EPA)/day) for 3 months. Controls took soybean oil capsules. Two questionnaires were administered 
and blood was taken at the start and end of the study. Two questionnaires were administered at the start and 
end of the study: Hostility-Aggression Questionnaire for Children (HAQ-C) and Barratt Impulsiveness 
Scale, version 11 (BIS-11), for measurement of aggression and impulsivity, respectively. Attendance was 
recorded during the study period. OUTCOMES: The concentrations of DHA and EPA in the phospholipid 
fraction in red blood cells were significantly increased in the DHA group. Behavior checked with HAQ-C 
or BIS-11 did not show any differences between groups. However, the odds ratio of inability to attend 
school regularly during the study period was 0.40 (95%CI: 0.23-0.71) in the DHA group compared with 
controls (p=0.002). CONCLUSIONS: DHA-rich fish oil may improve the school attendance rate of 
children in Lampung, Indonesia. 
㩷 㩷
㩷 4) Hamazaki T., Shimokawa H., Terashima Y., Itomura M., Hamazaki K., Nagasawa 
T.,Yamamoto J., and Jun Wu.: The Fatty Acid Composition of Red Blood Cells in Mildly 
Demented Dogs and of Commercially Available Dog Foods in Japan. J. Lipid Nutr. 17: 
163-171, 2008. 
㩷 Abstract: Summary: In order to investigate the relationship between the fatty acid composition of the 
dogs' tissue and dementia, we compared the fatty acid composition of red blood cells (RBCs) 
between 15 mildly demented dogs and 15 normal controls (҈10 years old). In the mildly demented dogs 
polyunsaturated fatty acids (PUFA) were significantly decreased and the ratios of arachidonic acid to total 
PUFA (AA/PUFA) were significantly increased compared with normal dogs. AA/PUFA ratios had a 
significant correlation with dementia scores of 30 dogs (r=0.48). Dog food analysis showed that the 
average n-6 fatty acids/n-3 fatty acids ratios, a parameter influencing AA/PUFA ratios in tissues, were 
very high in pellet-type dog foods (n=20, the ratios=12), In conclusion, high AA/PUFA values in RBCS 
might be a risk factor of mild dementia in dogs. It seems not prudent to provide AA supplements to mildly 
demented dogs.
㩷 㩷
㩷 5) Higashihara E., Nutahara K., Horie S., Muto S., Hosoya T., Hanaoka K., Tuchiya K., 
Kamura K., Takaichi K., Ubara Y., Itomura M., and Hamazaki T.: The effect of 
eicosapentaenoic acid on renal function and volume in patients with ADPKD. Nephrol Dial 
Transplant. 23: 2847-2852, 2008. 
㩷 Abstract: BACKGROUND: Soy protein ameliorates rat polycystic kidney disease with concomitant 
renal enrichment of omega3-polyunsaturated fatty acids. A study was conducted to examine the effects of 
eicosapentaenoic acids (EPA) on renal volume and function in patients with autosomal dominant 
polycystic kidney disease (ADPKD). METHODS: Non-azotemic patients were randomized to either a 
control group (n = 20) or an EPA group (n = 21). EPA capsules (2.4 g/day) were administered in the EPA 
group for 2 years. Twenty-four hours of urine was collected for the creatinine clearance (Ccr) 
measurement every year. At baseline and 24 months, fatty acid compositions in erythrocytes were 
measured and computerized tomographies were obtained for calculation of renal volume by the modified 
ellipsoid and volumetric methods. RESULTS: In the EPA group, the EPA concentration (1.80 +/- 0.99 
versus 4.40 +/- 1.79 area%, P < 0.001) and the omega3/omega6 ratio in the erythrocyte increased, but 
docosahexaenoic acid (DHA) (6.76 +/- 1.19 versus 5.64 +/- 1.45 area%, P < 0.010) concentration 
decreased. Ccr decreased by 8.5 +/- 9.5 and 9.0 +/- 13.0 ml/min/1.73 m(2)/2 years in the control and EPA 
groups, respectively (NS). The increases in renal volume calculated by either method were not 
significantly different between the two groups. CONCLUSIONS: A beneficial effect of EPA on renal 
function and kidney volume in ADPKD patients could not be confirmed in the present study. 
Administration of EPA with DHA supplementation and/or longer intervention might be necessary to 
demonstrate preventive effects of omega3-polyunsaturated fatty acids on progression of ADPKD. 
㩷 㩷
㩷 6) Itomura M., Terashima Y., Hamazaki K., Inoue K., Shirato N., Shibahara N., and Hamazaki 
T.: The Effects of a New Kanpo Formula, Hogen-ou, on Psychological Distress and 
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Low-Grade Inflammation㧙A Placebo-Controlled Double-Blind Study. Current Topics In 
Nutraceutical Research. 6:145-148, 2008. 
㩷 Abstract:  We manufactured a new kampo formula, Hogen-ou (HGO), a combination of Hogento 
(Baoyuantang in Chinese) and Bezoar bovis, expecting that HGO might be able to control stress. 
Apparently healthy volunteers were allocated either to the active (the HGO group, n=22) or to theplacebo 
group (n=25) in a double-blind manner. Subjects in the HGO group took 3g of HGO per day for12 weeks; 
those in the placebo group took indistinguishable placebo. At weeks 0 (the start of the study), 4, 8, 12 (the 
end of the study), the 30- item version of the General Health Questionnaire (GHQ-30) wasadministered. 
Blood samples were also collected. Blood chemistry including high-sensitivity C-reactiveprotein 
(hs-CRP) was assessed; blood cells were counted. There were no changes in GHQ-30 between two 
groups. No changes were detected in blood chemistry either. However, leukocyte counts were 
significantly lowered in the HGO group compared with the placebo group. We suggest that HGO had 
anti-inflammatory effects on low-grade inflammation in apparently healthy subjects.
㩷 㩷
㩷 7) Yoshizumi K., Murota K., Watanabe S., Tomi H., Tsuji T., and Terao J.: Chiisanoside is not 
absorbed but inhibits oil absorption in the small intestine of rodents. Biosci. Biotechnol. 
Biochem.ᴾ 72:1126–1129, 2008. 
㩷 Abstract: Chiisanoside is the main component of Acanthopanax sessiliflorus leaves. Simultaneous 
administration of chiisanoside resulted in a decrease in the plasma TG level and increase of undigested TG 
in the intestinal lumen after oil gavage to mice. This suggests that chiisanoside has the potential to prevent 
obesity as a lipase inhibitor which suppresses fat absorption in vivo. 
㩷 8) Watanabe S., Yamada Y., Dobashi K., and Saito M.: Scutellariae Radix augments ulceration 
but attenuates proinflammatory cytokine and chemokine gene induction in the small 
intestine during indomethacin-induced enteropathy in mice. J. Trad. Med. 25:55-59, 2008. 
㩷 Abstract: Our previous report described the enhancement of intestinal bleeding and anemia associated 
with indomethacin (INDO)-induced enteropathy in mice by oral administration of Scutellariae Radix (SR) 
extract. We here demonstrate that SR extract enhanced ulceration but attenuated the elevation of 
expression levels of interleukin (IL)-1E, IL-6 and CCL2 gene transcripts in small intestine during 
INDO-induced enteropathy. Our observations further support that INDO-induced enteropathy is 
aggravated by the oral administration of SR extract. This effect of SR extract may be due to the 
modulation of immune-inflammatory processes possibly through the suppression of proinflammatory 
cytokine and chemokine induction. 
㩷
㩷 9) Dobashi K., Ohkoshi E., Fujii Y., Nagai M. and Watanabe S.: Scutellariae Radix aggravates 
diclofenac sodium-induced enteropathy in mice. J. Trad. Med. 25:81-86, 2008. 
㩷 Abstract: We have reported that the oral administration of water extract of Scutellariae Radix (SR) 
enhances small intestinal ulceration and intestinal bleeding in the experimental enteropathy induced by 
subcutaneous injections of indomethacin (INDO) in mice. The present study was carried out to examine 
whether SR extract or SR-containing Kampo formula exerts similar effects in diclofenac sodium 
(Dic)-induced enteropathy in mice. We found that small intestinal ulceration and fecal hemoglobin (Hb) 
excretion in Dic-treated mice were enhanced by SR extract. However, such effects were not induced by 
pure baicalin (> 97%, w/w). Orengedokuto (OGT) did not enhance small intestinal ulceration but 
significantly enhanced fecal Hb excretion in Dic-treated mice. Our observations suggest a possibility that 
SR-containing Kampo formulas could aggravate non-steroidal anti-inflammatory drug-induced 
enteropathy. 
㩷 㩷
㩷 10) Saito M. and Watanabe S.: Differential modulation by dexamethasone treatment of 
lipopolysaccharide- and zymosan-induced hypophagia in mice. Pharmacol. Biochem. Behav. 
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90: 428-433, 2008.
㩷 Abstract: The treatment of experimental animals with lipopolysaccharide (LPS) induces behavioral 
depression, in which the central and peripheral inductions of proinflammatory cytokines are proposed to 
play an important role. We have shown that the intraperitoneal injection of zymosan, composed of 
insoluble particles prepared from yeast cell walls, can induce behavioral depression assessed as 
hypophagia in mice, although the role of proinflammatory cytokines in this response has not yet been 
investigated. We have also shown that the subcutaneous injection of the corticoid, dexamethasone (Dex), a 
potent inhibitor of cytokine production, is effective in attenuating hypophagia in LPS-treated mice. The 
attenuated response was associated with the suppression of the gene induction of proinflammatory 
cytokines (i.e., IL-1beta, IL-6 and TNFalpha) in the brain and liver. In contrast, no significant induction of 
proinflammatory cytokine genes was observed in the brain or liver during zymosan-induced hypophagia; 
the subcutaneous injection of Dex did not attenuate zymosan-induced hypophagia but its intraperitoneal 
injection did. Thus, zymosan-induced hypophagia was less responsive to a subcutaneous injection of 
dexamethasone than LPS-induced hypophagia, which may be due to the limited role of systemic 
inflammation in this response. An important role of localized, rather than systemic, inflammation in 
zymosan-induced hypophagia was suggested, although the role of local proinflammatory cytokines 
remains to be clarified. 
㩷
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